The Impact of Comorbid Nasal Polyps on Real-World Mepolizumab Effectiveness in Patients with Severe Asthma: Results from the REALITI-A Study

被引:0
|
作者
Liu, M. C. [1 ,2 ]
Bagnasco, D. [3 ]
Matucci, A. [4 ]
Pilette, C. [5 ,6 ]
Price, R. G. [7 ]
Maxwell, A. C. [8 ]
Cristancho, R. Alfonso [9 ]
Jakes, R. W. [10 ]
Yang, S. [9 ]
Howarth, P. [11 ]
Cheema, A. S. [12 ]
机构
[1] Johns Hopkins Asthma & Allergy Ctr, Div Clin Immunol & Allergy, Baltimore, MD USA
[2] Johns Hopkins Asthma & Allergy Ctr, Div Pulm & Crit Care Med, Baltimore, MD USA
[3] Univ Genoa, Osped Policlin San Martino, DIMI Dept Internal Med, Allergy & Resp Dis, Genoa, Italy
[4] Univ Florence, Azienda Osped Univ Careggi, Immunoallergol Unit, Florence, Italy
[5] UCLouvain, Clin Univ St Luc, Dept Pulm Med, Brussels, Belgium
[6] UCLouvain, Inst Expt & Clin Res, Brussels, Belgium
[7] GSK, Biostat, Stevenage, Herts, England
[8] GSK, Real World Study Delivery, Value Evidence & Outcomes, Global Med, Stevenage, Herts, England
[9] GSK, Value Evidence & Outcomes, Collegeville, PA USA
[10] GSK, Epidemiol, London, England
[11] GSK, Specialty Care TA, Global Med, Brentford, England
[12] Alpha Med Res, Mississauga, ON, Canada
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A4837
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Real-world effectiveness of mepolizumab in patients with severe asthma and associated comorbidities
    Casale, Thomas
    Molfino, Nestor A.
    Silver, Jared
    Bogart, Michael
    Packnett, Elizabeth
    McMorrow, Donna
    Wu, Joanne
    Hahn, Beth
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2021, 127 (03) : 354 - +
  • [42] Effectiveness of mepolizumab on severe asthma in Argentina: a real-world cohort study
    Colodenco, Daniel
    Yanez, Anahi
    Promencio, Federico
    Gattolin, Gabriel
    Maillo, Martin
    Bergna, Miguel
    Stok, Ana
    Sivori, Martin
    Vinuesa, Miguel
    Guendulain, Silvana
    Mengarelli, Maria Cecilia
    Galperin, Angeles
    Jousse, Maria Laura
    Zambelli, Martin
    Perelli, Lucas
    Noibi, Saeed
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [43] HEALTHCARE RESOURCE USE IN PATIENTS WITH SEVERE EOSINOPHILIC ASTHMA AFTER THE INITIATION OF MEPOLIZUMAB IN REAL-LIFE SETTINGS - REALITI-A STUDY
    Yang, S.
    Maxwell, A.
    Joksaite, S.
    Chaudhuri, R.
    Pastorello, E. A.
    Lee, J.
    Kohler, T. C.
    Ramos-Barbon, D.
    Schleich, F.
    Steven, G.
    Alfonso, R.
    VALUE IN HEALTH, 2020, 23 : S361 - S361
  • [44] UK severe asthma patient outcomes in the real-world versus Italy and the USA: REALITI-A at 2 years
    Weir, J.
    Egan, B.
    Heaney, L.
    Menzies, D.
    Pfeffer, P.
    Howarth, P.
    Chaudhuri, R.
    THORAX, 2023, 78 (SUPPL_4) : A184 - A184
  • [45] Real-world Evidence of Benralizumab in Patients With Severe Eosinophilic Asthma and Nasal Polyps: Initial Results of the RANS Study
    Le, T.
    Emmanuel, B.
    Kwiatek, J.
    Tran, T. N.
    Cohen, D.
    Kreindler, J. L.
    Katial, R.
    Daniel, S.
    Cao, Y.
    Shih, V.
    Gil Melcon, M.
    Devouassoux, G.
    Pelaia, G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [46] Real-world evidence of benralizumab in patients with severe eosinophilic asthma and nasal polyps: initial results of the RANS study
    Le, T.
    Emmanuel, B.
    Kwiatek, J.
    Cohen, D.
    Kreindler, J.
    Tran, T.
    Katial, R.
    Daniel, S.
    Coulter, H.
    Cao, Y.
    Shih, V.
    Melcon, M. Gil
    Devouassoux, G.
    Klimek, L.
    Pelaia, G.
    ALLERGOLOGIE, 2022, 45 (08) : 614 - 615
  • [47] Real-World Effectiveness of Mepolizumab in Patients with Severe Asthma: An Examination of Exacerbations and Costs
    Llanos, Jean-Pierre
    Ortega, Hector
    Bogart, Michael
    Packnett, Elizabeth R.
    Manjelievskaia, Janna
    Bell, Christopher F.
    Hahn, Beth
    JOURNAL OF ASTHMA AND ALLERGY, 2020, 13 : 77 - 87
  • [48] Effectiveness of benralizumab in asthma patients with comorbid nasal polyps: Results from the ZEPHYR 2 study
    Carstens, Donna
    Genofre, Eduardo
    Emmanuel, Benjamin
    Mu, Fan
    Young, Joshua A.
    ALLERGY AND ASTHMA PROCEEDINGS, 2022, 43 (06) : 565 - 565
  • [49] MEPOLIZUMAB IMPACT ON HEALTHCARE RESOURCE UTILIZATION AND WORK PRODUCTIVITY IN PATIENTS WITH SEVERE ASTHMA: REALITI-A 2-YEAR ANALYSIS
    Canonica, G. W.
    Howarth, P.
    Alfonso-Cristancho, R.
    Penz, E.
    Zhang, L.
    Bourdin, A.
    VALUE IN HEALTH, 2024, 27 (06) : S91 - S91
  • [50] REAL-WORLD MEPOLIZUMAB USE FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPS AND SEVERE ASTHMA IMPROVES CLINICAL/ECONOMIC OUTCOMES
    Cardet, J.
    Maldonado-Puebla, M.
    Silver, J.
    Laliberte, F.
    Gao, C.
    Hilts, A.
    Hwee, J.
    Edgecomb, A.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2024, 133 (06) : S93 - S94